-->

Sonde Health's Voice-Screening App Helps Companies Return to Work

Article Featured Image

Sonde Health today launched Sonde One, a voice-enabled health detection and monitoring app to help companies reopen in a rapidly changing COVID-19 environment.

Sonde One, leverages the company's advanced vocal biomarker platform and machine learning technology. With a single six-second voice sample, the app is designed to detect respiratory symptoms, such as coughing, shortness of breath, or chest tightness or pain. The app combines this voice analysis with a COVID-19 questionnaire and user inputted body temperature to give employees clear instructions about where they can work within one minute. Employers can deploy the solution to any number of staff anywhere.

"At Sonde, we believe that voice is a vital sign and a meaningful predictor of health," said David Liu, CEO of Sonde Health, in a statement. "By analyzing a few seconds of speech, we can detect subtle changes in a person's voice caused by common symptoms of respiratory disease. We built this capability into the Sonde One app so organizations can provide their employees with simple and fast COVID-19 monitoring in their pocket.:

To bring Sonde One to market, Sonde partnered with corporate wellness solutions provider Wellworks for You to make the tool available to its clients and their 1.4 million participating members.

"After months of remote work and distributed workforces, many employers want to get their employees back in the office; they're just not sure of the best way to do it," said Thomas Tegler, president of Wellworks for You, in a statement. "At Wellworks for You, we're always seeking better ways to promote employee wellness and preventative care, and in today's healthcare climate, Sonde Health provides a novel solution. Sonde One is an easy, non-invasive way for organizations to manage employee health risks during the pandemic and get workers back to the office safely."

SHI International, a provider of technology products and services, is the first enterprise to enroll. The company will begin implementing the Sonde One app in August as it gradually begins bringing employees back to the workplace, starting with its Somerset, N.J., headquarters.

"As we navigate this pandemic, our employees' health and wellness is our top priority," said Michael Haluska, vice president of human resources at SHI International, in a statement. "From the conference room to the warehouse floor, the Sonde One app will help us standardize our return-to-work policy to eliminate any confusion and keep all employees feeling safe."

Sonde One can be customized to each employer's return-to-work policy, giving employees clear guidance on whether they should report for physical duty following each screening. Additionally, a QR code can be delivered to employees within the app and scanned at an organization's front door to confirm compliance with protocols. Secure and customizable reporting capabilities enable employers to confirm employee participation, satisfy enterprise needs, and adhere to mandatory state guidelines surrounding employee screening and documentation.

Once an employer signs on, employees can download their employer-specific app via the App Store or Google Play on any smartphone.

SpeechTek Covers
Free
for qualified subscribers
Subscribe Now Current Issue Past Issues
Related Articles

Sonde Health Launches Self-Serve API that Detects Respiratory Disease from Voice Changes

Sonde Health's developer portal enables organizations to embed vocal biomarker health detection and monitoring in its mobile apps.

Sonde Health Acquires NeuroLex Labs

Sonde Health gains a voice survey and data acquisition platform with its acquisition of NeuroLex.

Sonde Health Announces Patents Covering Methods of Detecting Vocal Biomarkers in Physical or Psychological Conditions

Sonde Health Inc., an affiliate of PureTech Health developing a voice-based technology platform for monitoring and diagnosing mental and physical medical conditions, announced that the United States Patent and Trademark Office and Intellectual Property Australia have issued the company patents.